Applied Radiology
LOGIN TO YOUR MYAR CE ACCOUNT
Forgot Your Password? Register Submit
SA-CME
Accreditation/Designation Statement
The Institute for Advanced Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute for Advanced Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
These credits qualify as SA-CME credits.
Audience
Radiologists and related Medical Physicians
Emotional-intelligence-centric Leadership Training for Radiation Oncologists
Sarah E. Hoffe, MD; Joanne Quinn, PhD, MBA; Jessica Frakes, MD; Thomas J. Dilling, MD; Nadia A. Saeed, BA; Louis B. Harrison, MD
Estimated time for completion: 1 hour   •   Date of release and review: December 1, 2017   •   Expiration Date: November 30, 2019
Current residency training in radiation oncology does not incorporate leadership competency skills. Additionally, increasing administrative burdens in healthcare correlate with growing physician burnout and stress, but residency training has no systematic strategy to increase resiliency. Although simulation-based medical education (SBME) can incorporate teamwork, communication, and collaboration exercises at the undergraduate medical level, it has not been studied/incorporated at the national graduate level in radiation oncology. This article addresses the role of an emotional-intelligence (EI)-based leadership curriculum during such training.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Augmented and Virtual Reality: Exploring a future role in radiation oncology education and training
William Jin, Brandon Birckhead, MD; Bradford Perez, MD; Sarah Hoffe, MD
Estimated time for completion: 1 hour   •   Date of release and review: December 1, 2017   •   Expiration Date: November 30, 2019
The range of differences on the augmented/virtual reality AR/VR spectrum are mainly attributed to its depth of immersion. AR/VR technology is being used, through all spectrums of their devices, in surgery, imaging, medical student/resident/fellow education. The utility of AR/VR lies in its advantage to be massively scalable, reproducible, and realistic in simulating clinical environments. This article discusses how AR/VR technologies can cost-effectively enhance radiation oncology training.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Current controversies in prostate brachytherapy for prostate cancer
Ibrahim Abu-Gheida, MD; Christopher Fleming, MD; Paul Ramia, MD; Omar Mian, MD PhD; Rahul Tendulkar, MD; and Jay Ciezki, MD
Estimated time for completion: 1 hour   •   Date of release and review: September 1, 2017   •   Expiration Date: August 31, 2019
Indications for low dose rate prostate brachytherapy (LDR-BT) monotherapy for high-risk or unfavorable intermediate-risk prostate cancer are currently not based on level I evidence. Guidelines discussing brachytherapy indications do not highlight the important RTOG 0232 interim analysis regarding the role of LDR monotherapy and toxicity profile advantage, nor do guidelines highlight the dosimetric value of brachytherapy. This article summarizes the role of LDR-BT in managing prostate cancer and examines patient selection.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
High dose rate brachytherapy for prostate cancer: Current techniques and applications to varying disease presentations
Daniel J. Krauss, MD
Estimated time for completion: 1 hour   •   Date of release and review: September 1, 2017   •   Expiration Date: August 31, 2019
No direct clinical evidence supports the superiority of high-dose rate brachytherapy (HDR-BT) over low dose rate brachytherapy (LDR-BT), or vice versa, in terms of improved tumor control or reduced toxicity in patients with prostate cancer. This review fosters understanding of patient selection and technical description, examining HDR-BT in conjunction with external beam, and HDR-BT as monotherapy.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
A review of the role of external-beam radiation therapy in nonmelanomatous skin cancer
Bindu V. Manyam, MD; Nikhil Joshi, MD; Shlomo A. Koyfman, MD
Estimated time for completion: 1 hour   •   Date of release and review: June 1, 2017   •   Expiration Date: May 31, 2019
Much of the data supporting safety and efficacy of definitive radiation therapy (RT) in patients with non-mela-nomatous skin cancer (NMSC) is older, when its use was more common. Improvements are needed to better represent and cat-egorize high-risk disease. Treatment should be intensified with multimodality therapy for advanced disease. Clinicians must keep abreast of evolving treatment paradigms and novel systemic therapies NMSC. This article reviews indications, dosing, tech-niques, and outcomes for external-beam RT for NMSC.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Mycosis fungoides involving head and neck mucosal sites: Review of the literature
Aharon M. Feldman, MD; Parag Sevak, MD; Chauncey McHargue, MD; Henry W. Lim, MD; Farzan Siddiqui, MD, PhD
Estimated time for completion: 1 hour   •   Date of release and review: June 1, 2017   •   Expiration Date: May 31, 2019
Head and neck mycosis fungoides is uncommon, and few publications have been dedicated to this topic. Treatment options vary widely and include several radiation therapy regimens as well as medical management possibilities. Survival and treatment outcomes differ greatly depending on patient co-morbidities, treatment tolerance, and disease progression. This article will aid treatment selection and improve outcome predictions.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME credits select Profession below.
(Site Registration/Login Required)
Applied hepatobiliary scintigraphy in chronic gallbladder diseases
Mark Tulchinsky, MD, FACNM
Estimated time for completion: 1 hour   •   Date of release and review: September 1, 2016   •   Expiration Date: August 31, 2018
Educational gaps are responsible for a significant variability in methodological practice in the use of CCK-CS with calculation of GBEF in patients with suspected gallbladder diseases.  In addition, emerging evidence continues to refine the methodology of CCK-CS.  Clinicians must remain abreast of current recommendations and innovative practices in order to provide the most specific CCK-CS test results in patients with suspected FGBD.
This article will address the role of hepatobiliary scintigraphy (HBS) in the diagnosis and management of this often challenging clinical conundrum.
To View Supplement Click Here
To complete the Post-Exam and claim SA-CME or CE credits select Profession below.
(Site Registration/Login Required)